Forecasting essential childhood cancer drug need: An innovative model-based approach.
Terence M HughesBrianna EmpringhamAnita K WagnerZachary J WardJennifer YehSumit GuptaA Lindsay FrazierAvram E DenburgPublished in: Cancer (2021)
FORx ECAST enables needs-based estimates of childhood cancer drug volumes to inform health system planning in a wide range of contexts. It is broadly adaptable, allowing decision makers to generate results specific to their needs. The resultant estimates of drug need can help equip policymakers and health governance institutions with evidence-informed data to advance innovative procurement strategies that drive global improvements in childhood cancer drug access.